Numeric Investors’s Insys Therapeutics, Inc. INSY Stock Holding History

Numeric Investors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,000	Closed	-$344K	–	1189
2015 Q4	$344K	Sell	12,000 -8,100	-40%	-$224K	﹤0.01%	827
2015 Q3	$572K	Buy	+20,100	New	+$740K	0.01%	668
2015 Q2	–	Sell	-26,800	Closed	-$779K	–	1153
2015 Q1	$779K	Buy	+26,800	New	+$709K	0.01%	539
2014 Q2	–	Sell	-173,520	Closed	-$3.59M	–	954
2014 Q1	$3.59M	Sell	173,520 -80,976	-32%	-$1.61M	0.06%	275
2013 Q4	$3.28M	Buy	+254,496	New	+$3.53M	0.06%	285

Other funds holding INSY

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Numeric Investors's INSY Position: Q1 2016 in Review

Numeric Investors sold out of Insys Therapeutics, Inc. (INSY) in Q1 2016, closing a stake of 12,000 shares — an estimated $344K sold.

Numeric Investors first reported a position in INSY in Q4 2013 and held it in 5 quarters. The position peaked at $3.59M in Q1 2014. 138 funds tracked by Wall St. Rank hold INSY as of Q1 2016.

Numeric Investors reported no remaining Insys Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
Numeric Investors sold 12,000 Insys Therapeutics, Inc. shares in Q1 2016, an estimated $344K.
Numeric Investors first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 5 quarters.
Numeric Investors's Insys Therapeutics, Inc. position peaked at $3.59M in Q1 2014.
138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2016.

Based on Numeric Investors's 13F filing for Q1 2016, filed 6 May 2016.